Drugs / dinitrate isosorbide
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02258620 | Jun 2013 → Sep 2014 | coronary artery disorder | Brugmann University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dinitrate isosorbide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258620 ↗ |
| Known as | cedocard\* | “dinitrate isosorbide (cedocard\*) by continuous intra venous (1 to 5 mg/h) dinitrate isosorbide (cedocard\*) 5 mg by intra arterial direct in the sheat” NCT02258620 ↗ |
| Route | Intravenous | “continuous intra venous” NCT02258620 ↗ |